XOMA Financial Statements
XOMA Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
XOMA Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 84.3 | 29.5 | 18.7 |
| Gross Profit ($ mil.) | -- | 18.6 | -- |
| Operating Income ($ mil.) | (2.5) | (40.7) | (36.0) |
| Total Net Income ($ mil.) | (12.3) | (51.8) | 2.8 |
| Diluted EPS (Net Income) | (0.10) | (0.54) | 0.03 |
XOMA Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 12.1 | 14.7 | 43.1 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (13.0) | (9.1) | 22.7 |
| Total Net Income ($ mil.) | (14.2) | (9.9) | 21.8 |
| Diluted EPS (Net Income) | (0.11) | (0.08) | 0.18 |
XOMA Stock Quote & Chart
07/24/08 14:22:07 EST •
NASDAQ •
2.18
•
 +0.0100
•
+0.4608 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
XOMA Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.80 | 3.82 | 1.51 |
| Price/Earnings Ratio | -- | 15.93 | 15.01 |
| Price/Book Ratio | -- | 2.76 | 1.44 |
| Price/Cash Flow Ratio | -- | 11.64 | 9.38 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed XOMA Financial Ratios
XOMA Competitive Intelligence
| Abbott Labs | Amgen | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 14,771.0 | 48,418.0 |
| Employees | 68,000 | 17,500 | 86,600 |
| Market Cap ($ mil.) | 87,088.2 | 57,294.1 | 123,532.5 |
Competitive Landscape
